CJMB

Completion of a Partnership Agreement with Walker's Pharmaceuticals of India Establishes First On-Site International Partner Infrastructure Platform in Marion Positioned to Support National Pharmaceutical Resilience, Address US Security Concerns and Drive Economic Growth in Alabama Marion, AL, April 20, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced Atlas Complex by Callan JMB, a planned 150 acre campus in Marion, Alabama designed to support a significant

Spring Branch, TX, April 17, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today issued a statement in response to a recently filed lawsuit in the U.S. District Court for the Northern District of Texas. The complaint, filed by Eddie Patent Holdings, LLC, names Callan JMB among the defendants. The Company is currently reviewing the filing with legal counsel and believes the claims asserted in the complaint are without merit. "While we take all legal matters seriously, we

8-K - CALLAN JMB INC. (0002032545) (Filer)

Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its Established Emergency Preparedness Network SPRING BRANCH, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that under one of its longstanding Public Health Emergency Preparedness contracts, it has successfully executed the reverse distribution of critically needed vaccines and pharmaceuticals to several project areas in response to l

10-K - CALLAN JMB INC. (0002032545) (Filer)

8-K - CALLAN JMB INC. (0002032545) (Filer)

The Company Deepened its Government Relationships at Both State and Federal Levels, Particularly to Support Onshoring Initiatives, While Reinforcing the Strength and Stability of Core Emergency Preparedness Operations Built Momentum Across Several Growth Initiatives with Healthcare and Food Manufacturing Partners SPRING BRANCH, Texas, March 31, 2026 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its financial results for the full year ended December 31, 2025 an

Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale across multiple indications SPRING BRANCH, Texas, March 27, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB) ("Callan JMB" or the "Company"), an integrative logistics and operational infrastructure company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its role as an independent infrastructure and oversight partner in a collaboration led by DifGen Pharmaceuticals and Aveva Drug Delivery Systems, alongside Biostax Corp ("Biostax"), doing business

4 - CALLAN JMB INC. (0002032545) (Issuer)

8-K - CALLAN JMB INC. (0002032545) (Filer)

Callan JMB will Provide Independent Manufacturing Oversight and Governance as lodonal™ Undergoes Clinical Trials for Underserved Patient Population SPRING BRANCH, Texas, March 11, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that it has agreed with Biostax Corp d/b/a Attune Biotech Inc. ("Attune"), a clinical-stage biopharmaceutical company with a diversified therapeutic pipeline, to support its investigational new drug clinical trials for the treatment

4 - CALLAN JMB INC. (0002032545) (Issuer)

RALEIGH, NC / ACCESS Newswire / March 4, 2026 / iAccess Alpha today announced that it will host its Virtual Best Ideas Spring Investment Conference on March 10-11, 2026, bringing together a curated group of public companies and investors for two days of focused company presentations and 1x1 meetings.The conference will begin on Tuesday, March 10, 2026, with a series of live-streamed company presentations. The second day, Wednesday, March 11, 2026, will be dedicated to 1x1 meetings between presenting companies and pre-qualified investors.How to AttendInvestors and industry professionals can register to watch the presentations and request 1x1 meetings by visiting the official event website: ww

SPRING BRANCH, Texas, March 02, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced that Wayne Williams, Chief Executive Officer, Chairman & Founder, has been invited to attend the 50th International GMP Conference, on March 2-5, 2026 in Athens, Georgia. The conference is co-sponsored by the University of Georgia College of Pharmacy and U.S. Food & Drug Administration (FDA). Hosted annually since 1976, the conference offers a global forum where regulatory autho

SPRING BRANCH, Texas, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10-11, 2026. iAccess Alpha Virtual Best Ideas Spring Investment Conference Dates: March 10–11, 2026Location: VirtualPresentation Details: Tuesday, March 10, 2026 at 10:30am ETWebcast Link: https://www.webcaster5.com/Webcast/Page/3157/53626 For more information, please contact your i

SCHEDULE 13G/A - CALLAN JMB INC. (0002032545) (Subject)

8-K - CALLAN JMB INC. (0002032545) (Filer)

ATLANTIC CITY, NJ / ACCESS Newswire / January 23, 2026 / DealFlow Events today announced the growing list of companies scheduled to present and participate in one-on-one meetings with investors and analysts at the DealFlow Discovery Conference, taking place January 28-29, 2026, at the Borgata Hotel Casino & Spa in Atlantic City.More than 100 public and private companies are expected to participate in the conference, which brings together investors, analysts, growth company executives, and capital markets professionals for two days of company presentations, structured networking, and pre-scheduled 1:1 meetings.Below is the current list of companies confirmed to present and take meetings. Publ

SPRING BRANCH, Texas, Jan. 20, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced its participation in the DealFlow Discovery Conference on January 28-29, 2026. DealFlow Discovery ConferenceDates: January 28-29, 2026Location: The Borgata, Atlantic City, NJPresentation Details: Wednesday, January 28 at 3:00pm, in Room #3 For more information, please contact your DealFlow representative or email KCSA Strategic Communications at CallanJMB@kcsa.com. About Callan

Partnership Leverages Callan JMB's Federal Contract Experience, Cold Chain Infrastructure, and Strategic National Stockpile Relationships to Enable Immediate Deployment Readiness SPRING BRANCH, TX, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ:CJMB), ("Callan JMB" or the "Company"), an integrative logistics company empowering the healthcare industry and emergency management agencies through fulfillment, storage, monitoring, and cold chain logistics services, today announced it has signed a strategic teaming agreement with Biostax Corp d/b/a Attune Biotech Inc. ("Attune"), a clinical-stage biopharmaceutical company with a diversified therapeutic pipeline. Callan JMB will serve

GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically integrated temperature-controlled logistics and specialized life sciences fulfillment, today announced a comprehensive strategic realignment to address the critical infrastructure gap in the global distribution of GLP-1 (glucagon-like peptide-1) medications.As the pharmaceutical industry faces a logistics bottleneck due to the meteoric rise of weight-management and diabetes treatments such as Ozempic®, Wegovy®, and Mounjaro®, Callan JMB is positioning its proprietary cold-chain technology to become the primary "last-mile" fulfillment partner for large-scale telehealth and phar

4 - CALLAN JMB INC. (0002032545) (Issuer)

8-K - CALLAN JMB INC. (0002032545) (Filer)

4 - CALLAN JMB INC. (0002032545) (Issuer)

4 - CALLAN JMB INC. (0002032545) (Issuer)